(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

SKYCOVIONE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

SKYCOVIONE

ST13

US500000079329154

Classe

5

Pedido

79329154

Registro

7088836

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

42

Atualização mais recente

27/09/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5

Data de depósito

23/11/2021

Data de registro

27/06/2023

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

27/06/2023

Última transação

27/09/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

03

Localização do titular

KR

Examinador

LEE, DOUGLAS

Localização atual

Historical data usage

Titulares e representantes

Titulares

SK bioscience Co., Ltd.

Representantes

Hun Joon Kim LEX IP Meister, PLLC.

Classificação técnica

Classes Nice

Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Medicines for human purposesfor the treatment of respiratory infectious diseases and disorders; Veterinary preparations for the treatment of respiratory diseases and disorders; Drugs for medical purposesfor treating viral infections and respiratory diseases and disorders; Pharmaceuticals for human purposesfor treating viral infections and respiratory diseases and disorders; vaccines; * used for prophylactic and therapeutic treatments for infections of Sarbecovirusincluding SARS-CoV-1SARS-CoV-2any other coronavirus and any variant thereof. * veterinary vaccines; viral vaccines; human vaccine preparations; vaccines against pneumococcal infections; Medical diagnostic reagents for medical usenamely for detecting immunization disease; diagnostic agents for pharmaceutical use; * pharmaceutical products for the treatment of infectious diseases namely prophylactic and therapeutic treatments for infections of Sarbecovirusincluding SARS-CoV-1SARS-CoV-2any other coronavirus and any variant thereof * ; pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of viral diseases; antiviral agents; immunotherapeutic agents for bacterial infections; bacterial preparations for medical purposes; reagents for use in diagnostic tests for medical purposes; sterilizing washes; disinfectants for chemical toilets; Medical diagnostic test strips for blood analysisurine analysissaliva analysisnasal secretion analysis

Publicações

Histórico de despachos e eventos da marca no USPTO.

42 publicações encontradas

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

26/09/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

27/11/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

27/11/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

27/11/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

27/11/2024

LIME

LIMITATION FROM THE IB EXAMINED AND ENTERED

03/07/2024

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

02/07/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/07/2024

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

16/03/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

24/10/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

29/09/2023

FIMP

FINAL DISPOSITION PROCESSED

29/09/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

27/09/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

27/06/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

27/06/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

12/06/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

24/05/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

24/05/2023

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

22/05/2023

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

08/02/2023

GPNX

NOTIFICATION PROCESSED BY IB

24/01/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/01/2023

PUBO

PUBLISHED FOR OPPOSITION

10/01/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/01/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

04/01/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

21/12/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/12/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

29/11/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

28/11/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

28/11/2022

ATRV

ATTORNEY REVIEW COMPLETED

21/07/2022

LIME

LIMITATION FROM THE IB - REQUEST EXAM REVIEW

19/07/2022

RFNT

REFUSAL PROCESSED BY IB

22/06/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

28/05/2022

RFRR

REFUSAL PROCESSED BY MPU

28/05/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

26/04/2022

CNRT

NON-FINAL ACTION WRITTEN

25/04/2022

DOCK

ASSIGNED TO EXAMINER

19/04/2022

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

12/02/2022

MAFR

APPLICATION FILING RECEIPT MAILED

08/01/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/01/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

23/12/2021

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace SKYCOVIONE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.